FDA campaign H-0204-2025
Class IHazard
Listeria monocytogenes. During routine testing the firm received positive test results of Listeria monocytogenes on their finished product.
Distribution
Product was shipped to one customer in NC and did not reach retail stores.
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.